NCT05049785CompletedEarly phase 1
Nutrition and Physical Activity Intervention in Preventing Excess Weight Gain in Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone
Nutrition Intervention for Pediatric Patients With Leukemia or Lymphoma Treated With Prednisone and/or Dexamethasone
Source: ClinicalTrials.gov · Last updated 25 Jul 2025
Brief summary (registry, in English)
This trial studies how well a nutrition and physical activity intervention works in preventing excess weight gain in pediatric patients with leukemia or lymphoma treated with Treated with prednisone and/or dexamethasone. A nutrition and physical activity intervention may help develop healthier eating habits and prevent rapid excess weight gain in pediatric patients with leukemia or lymphoma who are receiving prednisone and/or dexamethasone.
- Status (registry)
- Completed
- Phase (registry)
- Early phase 1
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 9 Sept 2021
- Start date
- 12 May 2011
- Primary completion date
- 21 Jul 2025
- Lead sponsor
- M.D. Anderson Cancer Center
- Diseases
- Childhood cancers
- NCT number
- NCT05049785
What you commit to
- Study type: Interventional · Early phase 1
- Planned participants: 100
- From 12 May 2011 to the primary completion date, 21 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving nutrition counseling or weight management counseling elsewhere
- Pediatric patients who are already receiving steroids that are not part of treatment
Other illness
- History of psychological disorders as indicated in the medical record (eg: eating disorders, depression)
Who the study is looking for
- Leukemia or lymphoma patient at MD Anderson Children's Cancer Hospital
- Patients receiving prednisone and/or dexamethasone therapy at MD Anderson Children's Cancer Hospital at time of enrollment
- Karnofsky performance status greater than or equal to 70
- Must be cleared by treating oncologist to participate in study
- Must live close enough to attend measurement sessions at one of the clinical centers
Age in the registry: 7 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| M D Anderson Cancer Center Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.